Cigna Corp. (CI-N)
NYSE:CI
316.64
4.59
(1.47%) 1d
Financials
Technical Analysis
Related posts
Nervous markets await Nvidia
This summary was created by AI, based on 1 opinions in the last 12 months.
Cigna Corp. has demonstrated strong financial performance and managerial effectiveness, reflected in a compound annual growth rate (CAGR) of 13% in earnings per share (EPS) from 2013 to 2023. The market reacted negatively due to concerns about a potential tie-up with Humana, but Cigna's decision to withdraw from those discussions has been positively regarded given the challenges Humana faces. Cigna is actively engaging in share buybacks and distributing dividends, which showcases its commitment to returning value to shareholders. Analysts have set a price target of $397.05 for the stock, indicating optimism about its future performance. Overall, Cigna appears to be well-positioned, with capable management steering the company in a positive direction amidst market uncertainties.
Premium contentPremium contentPremium content(A Top Pick Sept 20/16. Up 43%.) He continues to like the US healthcare sector. In the US, if over 65 years of age, you spend 3X as much on healthcare as under the age of 65. This company doesn’t have much exposure to the Affordable Care Act and is well positioned to benefit from those trends.
(Top Pick Aug 17/16, Up 39.68%) A US based health insurance company. The news was that last year Anthem had made an offer for them, but he thought the takeover would not go through. There is a large break fee for the deal not going through. He thinks going forward they will buy back stock, invest and raise their dividend. It is another well run story.
A US health insurer provider, one of the largest. There is a pending deal. Aetna (AET-N) (?) wants to buy the company, and it is unlikely that deal gets approved. If the deal doesn’t get approved, the break fee is about $1.5 billion. On top of that, when you look at the cash they can deploy, they are going to have about $10 billion to play with. They can buy back a ton of stock if the deal does not go through. If it does go through, you still get 30% upside. Dividend yield of .03%.
Health care insurance space, global. A company wanted to buy them and it was rejected by the US government, but they have until next April for the deal to go through. 14 times earnings. They help companies save money. Once the deal does close, or doesn’t, they will have the ability to raise the dividend.
- «
- ‹
- 1
- ›
- »
Cigna Corp.(CI-N) Rating
Ranking : 1 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 0
Cigna Corp.(CI-N) Frequently Asked Questions
What is Cigna Corp. stock symbol?
Cigna Corp. is a American stock, trading under the symbol CI-N on the New York Stock Exchange (CI). It is usually referred to as NYSE:CI or CI-N
Is Cigna Corp. a buy or a sell?
In the last year, there was no coverage of Cigna Corp. published on Stockchase.
Is Cigna Corp. a good investment or a top pick?
Cigna Corp. was recommended as a Top Pick by on . Read the latest stock experts ratings for Cigna Corp..
Why is Cigna Corp. stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Cigna Corp. worth watching?
0 stock analysts on Stockchase covered Cigna Corp. In the last year. It is a trending stock that is worth watching.
What is Cigna Corp. stock price?
On 2025-05-30, Cigna Corp. (CI-N) stock closed at a price of $316.64.
Shares are down because the market fears they will do a tie-up deal with Humana, but CI bowed out. This is good given Human's problems. Managers are excellent, making good deals. EPS grew 13% compounded annual growth rate from 2013-2023. Are buying back shares and pay a dividend.
(Analysts’ price target is $397.05)